Scarica l'app Stockscreener
3.97
2.85%
0.11
Whitehawk Therapeutics Inc Borsa (WHWK) Ultime notizie
WHWK Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares Gain on Cost ControlEarnings Cycle Outlook - dars.gov.et
Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody Adc Development - marketscreener.com
Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development - Business Upturn
WHWKWhitehawk Therapeutics Inc Options - Finviz
Whitehawk Therapeutics, Inc.(NasdaqCM: WHWK) added to Russell 2000 Index - marketscreener.com
Whitehawk Therapeutics, Inc.(NasdaqCM: WHWK) added to Russell 2000 Value Benchmark - marketscreener.com
Whitehawk Therapeutics, Inc.(NasdaqCM:WHWK) added to Russell 3000E Value Benchmark - marketscreener.com
Price to sales forward of Whitehawk Therapeutics, Inc. – NASDAQ:WHWK - TradingView
Whitehawk Therapeutics, Inc.(NasdaqCM:WHWK) added to Russell Small Cap Completeness Index - marketscreener.com
Price to sales forward of Whitehawk Therapeutics, Inc. – FWB:3350 - TradingView
Enterprise value to revenue forward of Whitehawk Therapeutics, Inc. – NASDAQ:WHWK - TradingView
Enterprise value to revenue forward of Whitehawk Therapeutics, Inc. – FWB:3350 - TradingView
B. Riley Securities Initiates Whitehawk Therapeutics(WHWK.US) With Buy Rating, Announces Target Price $10 - Moomoo
Whitehawk Therapeutics, Inc. Actuals & Estimates (NASDAQ:WHWK) - TradingView
Whitehawk Therapeutics, Inc. Actuals & Estimates (DUS:3350) - TradingView
Price to earnings forward of Whitehawk Therapeutics, Inc. – NASDAQ:WHWK - TradingView
Enterprise value to EBITDA forward of Whitehawk Therapeutics, Inc. – NASDAQ:WHWK - TradingView
WHWK Initiated Coverage by B. Riley Securities -- Rating Set to Buy - GuruFocus
WHWK Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Whitehawk Therapeutics, Inc. – DUS:3350 - TradingView
B.Riley initiates Whitehawk Therapeutics stock rating at Buy on ADC portfolio - Investing.com Canada
Enterprise value to EBIT forward of Whitehawk Therapeutics, Inc. – NASDAQ:WHWK - TradingView
Price to book forward of Whitehawk Therapeutics, Inc. – DUS:3350 - TradingView
Whitehawk Therapeutics(WHWK) Stock Options Chain | Quotes & News - Moomoo
3 Penny Stocks With At Least $50M Market Cap To Watch - Sahm
Whitehawk Therapeutics (WHWK) director receives 38,040 stock options grant - Stock Titan
Whitehawk Therapeutics (WHWK) director granted 38,040 stock options at $4.16 strike - Stock Titan
Director Richard Maroun receives 38,040 stock options at Whitehawk (WHWK) - Stock Titan
Whitehawk Therapeutics (WHWK) director granted 38,040 stock options at $4.16 - Stock Titan
Whitehawk Therapeutics (WHWK) director receives 38,040 stock options at $4.16 - Stock Titan
Whitehawk Therapeutics (WHWK) director granted options on 38,040 shares - Stock Titan
Whitehawk (WHWK) grants 38,040 stock options to director Aghazadeh - Stock Titan
Whitehawk Shareholders Approve Directors, Pay and Auditor - The Globe and Mail
Whitehawk Therapeutics shareholders elect directors and approve proposals at annual meeting - Investing.com India
Shareholders of Whitehawk Therapeutics (NASDAQ: WHWK) approve directors, pay and auditor - Stock Titan
Is Whitehawk Therapeutics (WHWK) One Of The Hot Biotech Stocks Under $5 To Buy? - Insider Monkey
[EFFECT] Whitehawk Therapeutics, Inc. SEC Filing - Stock Titan
WHWK Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift StockMid-Term Outlook - newsline.com
Whitehawk Therapeutics (WHWK) Slides 5.7%, Eyes Crucial Support Near $3.94Linear Regression - dars.gov.et
Whitehawk Therapeutics Announces $87.5 Million Private Placement Financing - Global Legal Chronicle
Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference - marketscreener.com
Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 - The AI Journal
WHWK: Selling Stockholder Offers 22.32 Million Shares - GuruFocus
Whitehawk Therapeuticsfiles to offer and resell up to 22.32 million shares of common stock by selling stockholders - marketscreener.com
Whitehawk Therapeutics (WHWK) registers 22.3M shares after $87.5M placement - Stock Titan
Whitehawk CEO to speak at Jefferies 2026 healthcare gathering in NYC - Stock Titan
Whitehawk Therapeutics (WHWK) Edges Lower as Stock Hovers Near Key SupportHigh Volume Node - The Legal Advocate
WHWK: Innovative ADC platform shows strong clinical progress and industry validation for oncology targets - TradingView
WHWK News | WHITEHAWK THERAPEUTICS INC (NASDAQ:WHWK) - ChartMill
WHWK Q1 2026 Earnings: EPS Beat Drives Stock Rally Despite No RevenueGuidance Update - newsline.com
WHWK Q1 2026 Earnings: EPS Beat Drives Positive Sentiment Despite Revenue GapGuidance Update - The Legal Advocate
WHWK Stock Edges Up After Hours: Firm Boosts Pipeline Of Cancer Drugs On The Heels Of Capital Raise - Stocktwits
WHWK Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SharesGeographic Revenue Trends - The Legal Advocate
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):